Advancing epilepsy genetics in the genomic era

CT Myers, HC Mefford - Genome medicine, 2015 - Springer
Epilepsy is a group of disorders characterized by recurrent seizures, and is one of the most
common neurological conditions. The genetic basis of epilepsy is clear from epidemiological …

Solute carrier transporters as potential targets for the treatment of metabolic disease

T Schumann, J König, C Henke, DM Willmes… - Pharmacological …, 2020 - Elsevier
The solute carrier (SLC) superfamily comprises more than 400 transport proteins mediating
the influx and efflux of substances such as ions, nucleotides, and sugars across biological …

Clinical application of whole-exome sequencing across clinical indications

K Retterer, J Juusola, MT Cho, P Vitazka, F Millan… - Genetics in …, 2016 - nature.com
Purpose: We report the diagnostic yield of whole-exome sequencing (WES) in 3,040
consecutive cases at a single clinical laboratory. Methods: WES was performed for many …

Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families

AM Alazami, N Patel, HE Shamseldin, S Anazi… - Cell reports, 2015 - cell.com
Our knowledge of disease genes in neurological disorders is incomplete. With the aim of
closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous …

Lessons learned from additional research analyses of unsolved clinical exome cases

MK Eldomery, Z Coban-Akdemir, T Harel… - Genome medicine, 2017 - Springer
Background Given the rarity of most single-gene Mendelian disorders, concerted efforts of
data exchange between clinical and scientific communities are critical to optimize molecular …

Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test

J Thevenon, Y Duffourd, A Masurel‐Paulet… - Clinical …, 2016 - Wiley Online Library
The current standard of care for diagnosis of severe intellectual disability (ID) and epileptic
encephalopathy (EE) results in a diagnostic yield of∼ 50%. Affected individuals nonetheless …

The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity

DG Grimm, CA Azencott, F Aicheler, U Gieraths… - Human …, 2015 - Wiley Online Library
Prioritizing missense variants for further experimental investigation is a key challenge in
current sequencing studies for exploring complex and Mendelian diseases. A large number …

Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual …

S Nambot, J Thevenon, P Kuentz, Y Duffourd… - Genetics in …, 2018 - nature.com
Purpose Congenital anomalies and intellectual disability (CA/ID) are a major diagnostic
challenge in medical genetics—50% of patients still have no molecular diagnosis after a …

Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism

MJ Miller, AD Kennedy, AD Eckhart, LC Burrage… - Journal of inherited …, 2015 - Springer
Global metabolic profiling currently achievable by untargeted mass spectrometry-based
metabolomic platforms has great potential to advance our understanding of human disease …

[HTML][HTML] The solute carrier transporters and the brain: Physiological and pharmacological implications

C Hu, L Tao, X Cao, L Chen - Asian journal of pharmaceutical sciences, 2020 - Elsevier
Solute carriers (SLCs) are the largest family of transmembrane transporters that determine
the exchange of various substances, including nutrients, ions, metabolites, and drugs across …